Interferon-gamma regulation of C3 gene expression in human astroglioma cells

Barnum, 1990, C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute phase protein and is elevated in systemic lupus erythematosis, Compelement Inflamm., 7, 71, 10.1159/000463131 Barnum, 1990, Structure and function of C3, Vol. 6, 208 Barnum, 1990, Complement protein production and regulation in human astrocytes, FASEB J., 4, 1871 Benveniste, 1992, Cytokiens: Influence on glial cell gene expression and function, Vol. 52, 106 Bethea, 1990, Tumor necrosis factor production and receptor expression by a human astroglioma cell line, J. Neuroimmunol., 30, 1, 10.1016/0165-5728(90)90047-Q Bignami, 1972, Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence, Brain Res., 43, 429, 10.1016/0006-8993(72)90398-8 Bigner, 1981, Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas, J. Neuropath. Exp. Neurol., 40, 201, 10.1097/00005072-198105000-00001 Bradbury, 1984, Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological sera, J. Neurol. Sci., 65, 293, 10.1016/0022-510X(84)90092-3 Brooimans, 1990, Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-γ and IL-1, J. Immunol., 144, 3835 Chirgwin, 1979, Isolation of biologically active ribonucleic acid from sources rich in ribonuclease, Biochemistry, 18, 5294, 10.1021/bi00591a005 Cole, 1988, Complement biosynthesis, 44 Compston, 1987, Cerebrospinal fluid complement components in multiple sclerosis, 201 Cyong, 1982, Antibody-independent complement activation by myelin via the classical complement pathway, J. Exp. Med., 155, 587, 10.1084/jem.155.2.587 Danielson, 1988, A cDNA clone of the rat mRNA encoding cyclophilin, DNA, 7, 261, 10.1089/dna.1988.7.261 De Bruijn, 1985, Human complement component C3: cDNA coding sequence and derived primary structure, 82, 708 Domdey, 1982, Characterization of the mRNA and cloned cDNA specifying the third component of mouse complement, 79, 7619 Feinberg, 1983, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem., 132, 6, 10.1016/0003-2697(83)90418-9 Fontana, 1982, Production of prostaglandin E and an interleukin-1 factor by cultured astrocytes and C6 gliioma cells, J. Immunol., 129, 2413 Hamilton, 1987, Modulation of monocyte complement synthesis by interferons, Biochem. J., 242, 809, 10.1042/bj2420809 Hopkins, 1989, Simple, sensitive and specific bioassay of interleukin-1, J. Immunol. Methods, 120, 271, 10.1016/0022-1759(89)90252-4 Knowles, 1980, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science, 209, 497, 10.1126/science.6248960 Koski, 1987, Activation of terminal components of complement in patients with Bullain-Barré syndrome and other demyelinating diseases, J. Clin. Invest., 80, 1492, 10.1172/JCI113231 Levi-Strauss, 1987, Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation, J. Immunol., 139, 2361 Linington, 1988, Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein, Am. J. Pathol., 130, 443 Panitch, 1987, Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system, Neurology, 37, 1097, 10.1212/WNL.37.7.1097 Price, 1980, Cerebrospinal fluid complement proteins in neurological disease, J. Neurol. Sci., 46, 49, 10.1016/0022-510X(80)90042-8 Raine, 1990, Multiple sclerosis: Immunopathologic mechanisms in the progression and resolution of inflammatory demyelination, 37 Rodriguez, 1990, Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls, Neurology, 40, 855, 10.1212/WNL.40.5.855 Rothman, 1990, Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line A549, J. Immunol., 145, 592 Shin, 1992, The complement system Strunk, 1985, γ-Interferon increases expression of Class III complement genes C2 and Factor B in human monocytes and in murine fibroblasts transfected with human C2 and Factor B genes, J. Biol. Chem., 260, 15280, 10.1016/S0021-9258(18)95732-7 Sundstrom, 1976, Establishment and characterization of a human histiocytic lymphoma cell line (U937), Int. J. Cancer, 17, 565, 10.1002/ijc.2910170504 Takiguchi, 1985, Response of glial cells to γ-interferon, Eur. J. Immunol., 15, 809, 10.1002/eji.1830150813 Traugott, 1988, Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions, J. Neurol. Sci., 84, 257, 10.1016/0022-510X(88)90130-X Vanguri, 1982, Complement activation by isolated myelin: Activation of the classical pathway in the absence of myelin-specific antibodies, 79, 3290 Vidovic, 1990, Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α, J. Neuroimmunol., 30, 189, 10.1016/0165-5728(90)90103-T Warren, 1987, The third component of complement is transcribed and secreted by cultured endothelial cells, Am. J. Pathol., 129, 9 Wilson, 1990, A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6, Mol. Cell. Biol., 10, 6181, 10.1128/MCB.10.12.6181 Yam, 1980, Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis, Clin. Immunol. Immunopathol., 17, 492, 10.1016/0090-1229(80)90145-2 Yasukawa, 1987, Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6), EMBO J., 6, 2939, 10.1002/j.1460-2075.1987.tb02598.x